Agwu Health, Inc.

Website
Consumer,HealthTech

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Onyekachi Amadi, Margarita Sandoval
Pre-Seed
United States
Consumer, HealthTech
2026
Agwu sells a $34.99/month subscription directly to patients with reproductive health conditions like PCOS, fibroids, and endometriosis, giving them matched access to NPI-verified specialists and continuity of care across their treatment journey. Individual specialists don't pay to be on the platform. Our second revenue channel is B2B2C: we sell into health groups and insurers who run their own EHR systems, since Agwu drives new patient flow directly into those systems, making us a patient acquisition tool for them rather than a cost. Longer term, we plan to add a premium tier around $69/month with telehealth access, starting with peptide therapy prescriptions, to increase revenue per user without changing how we acquire patients.

Agwu matches women with reproductive conditions to vetted specialists and manages care long-term. Subscription plus B2B2C revenue via insurers and health groups. Specialist network grew 3.5x in weeks, 100 patients live in beta.